Abstract # 2125 Concurrent Chemoradiotherapy with Full-dose Gemcitabine for Unresectable Pancreatic Cancer

Presenter: Nakamura, Satoaki

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

This regimen of concurrent full-dose gemcitabine and radiotherapy, omitting prophylactic lymph node irradiation achieved a favorable survival and was well tolerated. The restricted PTV volume is supposed to be one of the empirical factors.